Greenwich LifeSciences, Inc. (GLSI) — real insider trading activity disclosed to the SEC, tracked automatically as new Form 4 filings are reported. Most recent: Patel Snehal — 2 open-market purchases between 2026-07-23 and 2026-07-24, totaling $47,018.
Transactions disclosed by company insiders to the SEC on Form 4, most recent first.
| Insider | Role | Date | Shares | Value |
|---|---|---|---|---|
| Patel Snehal | CEO and CFO | 2026-07-29 | 700 | $9,170 |
| Patel Snehal | CEO and CFO | 2026-07-28 | 1,500 | $20,385 |
| Patel Snehal | CEO and CFO | 2026-07-27 | 1,500 | $20,430 |
| Patel Snehal | CEO and CFO | 2026-07-24 | 1,100 | $14,168 |
| Patel Snehal | CEO and CFO | 2026-07-23 | 2,500 | $32,850 |
Position changes disclosed in SEC Form 13F filings. These report a quarterly snapshot, not exact trade dates.
| Fund | Change | Quarter |
|---|---|---|
| Bank of New York Mellon Corp | Bank of New York Mellon Corp increased this position by 664% ($100,638 -> $769,160). | 2026-06-30 |
| Informed Momentum Co LLC | Informed Momentum Co LLC exited a position previously worth $514,749. | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | VANGUARD CAPITAL MANAGEMENT LLC reduced this position by 9% ($7,164,349 -> $6,526,337). | 2026-06-30 |
| SEI INVESTMENTS CO | SEI INVESTMENTS CO exited a position previously worth $626,634. | 2026-06-30 |
| Ancora Advisors LLC | Ancora Advisors LLC reduced this position by 72% ($900,750 -> $251,960). | 2026-06-30 |
| GOLDMAN SACHS GROUP INC | GOLDMAN SACHS GROUP INC increased this position by 274% ($246,854 -> $922,658). | 2026-06-30 |
| Russell Investments Group, Ltd. | Russell Investments Group, Ltd. reduced this position by 97% ($217,281 -> $6,311). | 2026-06-30 |
| STIFEL FINANCIAL CORP | STIFEL FINANCIAL CORP opened a new position worth $235,141. | 2026-06-30 |
Largest reported positions as of 2026-06-30.
| Fund | Value | Shares |
|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | $6,526,337 | 278,190 |
| GEODE CAPITAL MANAGEMENT, LLC | $3,372,113 | 143,692 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,896,999 | 80,861 |
| VANGUARD FIDUCIARY TRUST CO | $1,078,339 | 45,965 |
| GOLDMAN SACHS GROUP INC | $922,658 | 39,329 |
| Bank of New York Mellon Corp | $769,160 | 32,786 |
| STATE OF WISCONSIN INVESTMENT BOARD | $531,111 | 22,639 |
| STRS OHIO | $417,588 | 17,800 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $401,119 | 17,098 |
| Sixth Street Partners Management Company, L.P. | $401,119 | 17,098 |
Data compiled from public SEC filings. This is informational reporting, not investment advice.
Greenwich LifeSciences, Inc. (NASDAQ: GLSI) just logged a fresh open-market purchase from its top executive, and it’s the second one in as many days — the kind of clustered buying pattern that tends to catch the attention of anyone screening for the biggest insider buys this week. According to a Form 4 filed with the … Read more